BabyOrgano, a growing D2C brand in India, has raised ₹20 crore in a pre-Series A round led by RPSG Capital Ventures, with continued backing from Sauce.vc. This funding is a key moment for the brand, showing investors believe in the growth of direct-to-consumer businesses in India, especially those focused on Ayurveda-based wellness for kids. This market is growing fast as parents look for natural, chemical-free ways to keep their kids healthy.
Founded in 2020 by Riddhi and Ripul Sharma, BabyOrgano combines Ayurveda products with a D2C approach, serving over a million parents who trust the brand for their kids’ health needs. With over 40% repeat purchases, a sign of strong customer loyalty, the brand is planning to expand quickly. The new funding will help them create new products, grow their distribution, invest in their supply chain, and expand across different sales channels, strengthening their D2C model as they aim for ₹100 crore in revenue by FY27. This goal fits with the trend of fast-growing D2C brands building a presence on e-commerce sites, their own websites, and in retail stores.
BabyOrgano offers products like immune boosters, cough and cold remedies, digestive aids, and daily health products. This range shows a strong D2C product launch strategy, supported by storytelling, trust-building, and convenient formats for parents. As Ayurveda-based preventive care becomes more popular in India, BabyOrgano is growing alongside companies like Mother Sparsh and Kapiva Kids, while competing with established brands like Dabur, Himalaya BabyCare, The Moms Co., Chicco, and Mamaearth’s kids line.
This funding contributes to the rise in D2C industry as investors support brands focused on trust, wellness, and everyday needs. With private equity and venture capital firms investing in D2C brands in family care and wellness, the market is set for long-term growth. BabyOrgano’s funding is among this week’s top D2C funding and India’s growing set of top funded D2C brands working toward growth and profit.
Their plan aligns with D2C market trends—omnichannel retail, purpose-driven brand messages, Ayurveda-based differentiation, and digital parent communities. As parenting communities and expert voices play a bigger role in D2C brand building, BabyOrgano’s focus on trust puts them in a good spot in the sensitive area of child wellness. With a sharper go-to-market plan, supply chain improvements, and operational focus, the company is preparing for future growth, while becoming a case study in supply chain and product design.
The kids’ Ayurvedic wellness market is underserved but has high trust and habits, making it a good chance for new D2C companies to grow in essential care markets. As investor interest grows around D2C startup value, angel investment, and future Series A funding, BabyOrgano’s progress adds to positive signs in India’s D2C space. While the industry watches for D2C IPOs, acquisitions, and potential exits, early winners like BabyOrgano are setting the stage for future growth in kids’ wellness and preventive care, mixing trust, tradition, product and customer experience.
BabyOrgano’s funding shows a clear message: sustainable, Ayurveda-inspired, trust-based kids’ wellness is a real trend.
